Free Trial

Credit Agricole S A Has $6.25 Million Position in The Cooper Companies, Inc. $COO

Cooper Companies logo with Medical background

Key Points

  • Credit Agricole S A has reduced its stake in The Cooper Companies by 29.7%, selling 31,264 shares and retaining a total of 74,113 shares valued at approximately $6.25 million.
  • Other institutional investors have increased their holdings in The Cooper Companies, with Hsbc Holdings PLC growing its stake by 3.1% and Dimensional Fund Advisors LP increasing its stake by 4.1%.
  • Cooper Companies reported earnings of $0.96 per share for the last quarter, exceeding expectations, and set FY 2025 guidance between $4.050 to $4.110 EPS.
  • Looking to export and analyze Cooper Companies data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Credit Agricole S A cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 74,113 shares of the medical device company's stock after selling 31,264 shares during the quarter. Credit Agricole S A's holdings in Cooper Companies were worth $6,251,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies in the 1st quarter valued at $33,000. City Holding Co. purchased a new stake in shares of Cooper Companies in the 1st quarter valued at $34,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies during the first quarter worth about $40,000. Larson Financial Group LLC increased its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after acquiring an additional 664 shares during the last quarter. Finally, HM Payson & Co. increased its holdings in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after acquiring an additional 532 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on COO shares. Loop Capital set a $100.00 price objective on Cooper Companies in a report on Tuesday, June 17th. Robert W. Baird decreased their target price on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a research report on Tuesday, July 22nd. Mizuho decreased their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Finally, UBS Group raised Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $96.73.

View Our Latest Stock Analysis on COO

Cooper Companies Trading Up 3.0%

Shares of COO stock traded up $2.18 during mid-day trading on Friday, hitting $75.22. 1,992,159 shares of the company's stock were exchanged, compared to its average volume of 1,597,715. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The stock has a 50-day simple moving average of $72.18 and a two-hundred day simple moving average of $78.08. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The stock has a market cap of $15.04 billion, a price-to-earnings ratio of 36.51, a PEG ratio of 1.83 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines